Civilization Ventures


Civilization Ventures is a venture capital firm focused on investing in scientific founders who are pioneering cutting-edge innovations in health tech and biology. The firm emphasizes a founder-centric approach, providing mentorship and support to help entrepreneurs reach their full potential. With a mission to back disruptive innovations that advance human longevity, Civilization Ventures manages over $100 million in capital and has partnered with more than 60 innovative companies. Their investment focus includes genomics, diagnostics, digital health, and synthetic biology.


What We Do

Civilization Ventures provides mentorship and strategic guidance to founders, leveraging their team of experienced biopharma executives and life sciences leaders to help entrepreneurs succeed.

The firm offers a unique Fellowship program to train PhDs to become entrepreneurs, fostering the growth of future life sciences founders and investors.

Civilization Ventures helps founders succeed through their vast network of industry experts, academics, and clinicians, providing access to leading innovations and resources.



Portfolio

Rocket Pharma has multiple first-in-class gene therapies in clinical trials to cure devastating inherited diseases.

#Gene Therapy

Singular Bio was acquired to help increase access to accurate genetic screening in early pregnancy.

#Genetic Screening

Lemonaid Health was acquired in a landmark $400M acquisition by 23andme.

#Telemedicine

Rewrite was acquired for $200M, marking a key move in the gene editing industry.

#Gene Editing

Foresight Diagnostics focuses on ultrasensitive diagnostics to catch cancer earlier and save lives.

#Diagnostics

BillionToOne is revolutionizing prenatal disease detection and cancer diagnostics by catching one molecule in a few billion.

#Diagnostics

Omada Health provides virtual care solutions leveraging digital wearables to treat and manage chronic conditions such as diabetes.

#Digital Health

Rzero focuses on creating safer, healthier indoor environments through innovative disinfection solutions.

#Planetary Impact

Sensible Biotechnologies is advancing synthetic biology to develop new therapeutic solutions.

#Synthetic Biology + Therapeutics

Siren Bio is focused on developing synthetic biology solutions for therapeutic applications.

#Synthetic Biology + Therapeutics

Tacit Therapeutics is innovating in the field of synthetic biology to create new therapeutic options.

#Synthetic Biology + Therapeutics

Teiko Bio is developing advanced diagnostic tools to improve healthcare outcomes.

#Diagnostics + Tools

TenSixty Bio is leveraging synthetic biology to create novel therapeutic solutions.

#Synthetic Biology + Therapeutics

TigaTx is focused on developing synthetic biology-based therapeutics.

#Synthetic Biology + Therapeutics

Ulab is integrating digital health and AI to enhance healthcare delivery.

#Digital Health + AI

Verbal is utilizing AI to transform digital health solutions.

#Digital Health + AI

Wild Earth is committed to creating sustainable, plant-based pet foods.

#Planetary Impact

Wyndly is using AI to personalize allergy treatment plans.

#Digital Health + AI

YourChoice Therapeutics is developing non-hormonal contraceptive solutions using synthetic biology.

#Synthetic Biology + Therapeutics

xCures is applying AI to optimize cancer treatment plans.

#Digital Health + AI


Key People

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.